During the past decade, Michel Ovize conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Michel Ovize" are "Acute Myocardial Infarction" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Michel Ovize" in a lesser frequency.

Most popular intervention types in "Michel Ovize" are "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Postconditioning" (1 trials), "ciclosporine A" (1 trials) and "standard angioplasty" (1 trials). Other intervention names were less common.

The vast majority of trials in "Michel Ovize" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Michel Ovize". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Michel Ovize, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Michel Ovize, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".